Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback Lensar said that its deal with Alcon is unlikely to receive necessary regulatory approvals in the U.S. by April 23 or even by July 23.
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural tear production.
Alcon Eyes Surgical Edge With LENSAR Buyout: Details Alcon is set to acquire LENSAR Inc. in a $356 million deal. This acquisition includes LENSAR's advanced cataract laser technologies, boosting Alcon's offerings in femtosecond laser-assisted cataract surgery.
LENSAR - Top Healthcare Equipment Stock LENSAR, Inc., a commercial-stage medical device company.
LNSR Stock Earnings: LENSAR Misses EPS, Beats Revenue for Q2 2024 LNSR stock results show that LENSAR missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
3 Under-$10 Stocks With the Potential to Make You a Millionaire Buying stocks under $10 might be one of the best ways to breach that million mark. Take a look at these three potential candidates.
LNSR Stock Earnings: LENSAR Beats EPS, Beats Revenue for Q1 2024 LNSR stock results show that LENSAR beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Earnings Scheduled For March 4, 2024 Companies Reporting Before The Bell • Sohu.com (
NASDAQ:SOHU ) is estimated to report earnings for its fourth quarter.
Stocks That Hit 52-Week Lows On Wednesday During Wednesday's session, 107 stocks hit new 52-week lows.
